Genetic tests | Belgian Genetic Tests database

Statistics

Type	Total	Last update
Genetic tests	859	2024-02-16
Diseases	4232	2023-06-22
Analytes	6169	2023-12-20
Gene panels	380	2024-03-20

Full name	Analytes	Gene panels	Disease	Laboratory
Dihydropyrimidine dehydrogenase deficiency/5-fluorouracil toxicity - Pharmacogenetics (4 variants: DPYD2A, DPYD13, c.2846A>T, HapB3)	DPYD		5-fluorouracil toxicity	Centrum Medische Genetica - UZ Antwerpen
5-fluorouracil (5-FU) toxicity - DPYD sequencing (all exons) - Pharmacogenetics	DPYD		5-fluorouracil toxicity	Centre de Génétique Médicale UCL
Dihydropyrimidine dehydrogenase deficiency (5-fluorouracil (5-FU) toxicity) - Pharmacogenetics	DPYD		5-fluorouracil toxicity, Dihydropyrimidine dehydrogenase deficiency	Centre de Génétique Humaine - CHU Sart-Tilman
5-fluorouracil toxicity - DPYD genotyping (4 hot spot mutations - DPYD2A, DPYD13, D949V, HapB3) - Pharmacogenetics	DPYD		5-fluorouracil toxicity	Centre de Génétique Médicale UCL
Dihydropyrimidine dehydrogenase deficiency; 5-fluorouracil toxicity - pharmacogenetics (4 variants: DPYD2A, DPYD13, c.2846A>T, HapB3) - Pharmacogenetics	DPYD		Dihydropyrimidine dehydrogenase deficiency	Centrum Medische Genetica - UZ Gent
Dihydropyrimidine dehydrogenase deficiency/5-fluorouracil toxicity - Pharmacogenetics (4 variants: DPYD2A, DPYD13, c.2846A>T, HapB3)	DPYD		Dihydropyrimidine dehydrogenase deficiency	Centrum Menselijke Erfelijkheid - KUL
Polyarteritis nodosa, childhood-onset / Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome	ADA2		Vasculitis due to ADA2 deficiency, Diamond-Blackfan anemia, Sneddon syndrome	Centrum Menselijke Erfelijkheid - KUL
MODY : Maturity onset Diabete of the Young (gene panel)	ABCC8, GCK, HNF1A, HNF4A, HNF1B, INS, KCNJ11	MODY - Maturity onset Diabete of the Young (21 genes) - IPG	MODY	Centre de Génétique-Institut de Pathologie et de Génétique (IPG)
Resistance to vitamin K antagonists - VKORC1 sequencing (all exons ) - Pharmacogenetics	VKORC1		Resistance to vitamin K antagonists, Prediction of resistance to vitamin K antagonists	Centre de Génétique Médicale UCL
Vitamin K antagonists toxicity or dose selection - VKORC1 genotyping (-1639G>A + 1173C>T) - Pharmacogenetics	VKORC1		Vitamin K antagonists toxicity or dose selection, Prediction of toxicity or dose selection of vitamin K antagonists	Centre de Génétique Médicale UCL
Deficiency of Vitamin K-Dependent Clotting Factors	VKORC1, GGCX		Hereditary combined deficiency of vitamin K-dependent clotting factors	Centrum Medische Genetica - UZ Gent

Did not find what you were looking for? Contact us through the support center.